Daily Journal Staff Writer
A biotech startup represented by Latham & Watkins LLP is gearing up to go public in November after months of consultation and planning with the Los Angeles-based global law firm, known for its familiarity with companies in the life sciences arena.
The company, which has yet to formally announce its planned public offering, was previously represented by a well known New York firm. But in i...
To continue reading, please subscribe.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$895, but save $100 when you subscribe today… Just $795 for the first year!
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$895, but save $100 when you subscribe today… Just $795 for the first year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In



